In 2017, he finished his PhD at Hospital La Paz in Madrid, analyzing immune response in several diseases, including sepsis. He published more than 25 papers in 5 years but decided to pivot his career by joining the d·HEALTH Barcelona program promoted by Biocat. During the program, he did a clinical immersion at Institut Guttmann, where he came up with the idea that has led to his start-up: Loop Dx.
He has a degree in Industrial engineering and an MBA from IESE. He worked for the Werfen group for 25 years, as general manager of the Group Hospital, and has started up several companies that manufacture and/or distribute products in the medical sector since 2003: Nefro-Ión (2003), Cardiolink (2004), Ilerimplant (2005) and Swan Medical (2016).
Maria Berruezo's resume isn't what you would normally expect of a digital health entrepreneur. She has a degree in Advertising and Strategic Relations and a master in Knowledge Management. She founded her own communication agency. Becoming a mother, however, turned her professional career on its head: she trained as a lactation consultant and founded LactApp, which brings together all of her interests: breastfeeding, women, social impact and communication.
Albert Jané has a degree in Biotechnology and Biochemistry from the UAB and a Master in Experimentation in Pharmaceutical Sciences. He has worked in R&D, quality control and customer service departments at several companies in the chemistry and textile sectors. In 2009, he co-founded Vytrus Biotech and is CEO of the company.
He has a PhD in Genomics and spent more than ten years doing research in biotechnology and genetics, with over 35 papers published in high-impact scientific journals. In 2013, he founded Sequentia with Riccardo Aiese Cigliano and currently balances his position at the helm of the company with teaching, giving classes in genomics at universities in Spain (UAB and UPF) and Italy (Sapienza, in Roma, and Federico II, in Naples). He is a councilor for the Italian Society of Agricultural Genetics (SIGA) and works to promote proper use of green biotechnology.
PhD in Chemistry from the University of Barcelona, his early career as a researcher was focused on the design and synthesis of bioactive peptides. He undertook postdoctoral studies in protein engineering and chemistry at the University of Rockefeller (New York) for six years. Later he joined Princeton University and headed the protein spectroscopy unit at the Department of Chemistry. He returned to Barcelona in 2014 and co-founded ProteoDesign, of which he is CEO and Chief Science Officer.